Skip to main content

Table 1 Basic clinicopathological molecular characteristics of 240 colorectal cancer patients

From: Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes

Variable No. of patients (%)
Sex
 Male 146 (60.8%)
 Female 94 (39.2%)
Age
 < 75 206 (85.8%)
 ≥ 75 34 (14.2%)
Location
 Right 66 (27.5%)
 Left 174 (72.5%)
Pathological differentiation
 Poor 77 (32.1%)
 Moderate 159 (66.3%)
 Well 4 (1.7%)
T stage
 T2 11 (4.6%)
 T3 143 (59.6%)
 T4 74 (30.8%)
 NA 12 (5.0%)
N stage
 N0 73 (30.4%)
 N1 71 (29.6%)
 N2 70 (29.2%)
 NA 26 (10.8%)
M stage
 M0 49 (20.6%)
 M1 191 (79.6%)
Stage
 I 0 (0.0%)
 II 14 (5.8%)
 III 32 (13.3%)
 IV 191 (79.6)
MS
 MSS 158 (65.8%)
 MSI 6 (2.5%)
 NA 76 (31.7%)
KRAS
 Wild-type 48 (20.0%)
 Mutation-type 33 (13.7%)
 NA 159 (66.3%)
NRAS
 Wild-type 46 (19.2%)
 Mutation-type 1 (0.4%)
 NA 193 (80.4%)
HRAS
 Wild-type 46 (19.2%)
 Mutation-type 0 (0.0%)
 NA 194 (80.8%)
BRAF
 Wild-type 59 (24.6%)
 Mutation-type 1 (0.4%)
 NA 180 (75.0%)
  1. NA not applicable